1 April 2023
Acquisition of Weidmann’s North American Diagnostic Laboratory business and InsuLogix® monitoring product line by the Megger Group
On March 31, 2023, Weidmann Group concluded the sale of their North American Diagnostic Laboratory business and InsuLogix® brand including monitoring products HMA and B to Megger Ltd, Dover, UK.
We take this opportunity to thank our employees who will be transitioning to Megger and, in addition, thank our customers for their loyalty and business over the past years.
Megger is an organization representing the values that we hold at Weidmann, owning a rich history within our industry. We are confident they will continue to serve our customers at the highest level and bring additional value through their extensive products and services offered.
We believe that many synergies exist between our organizations and expect this to be the first step in defining a partnership for the future that allows both companies to maximize the value they bring to different customer bases.
For further information, please visit: www.avodiagnostics.com